TCL Archive FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion January 3, 1992
TCL Archive More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene August 28, 2009